Abstract Design and development of new drug molecules are essential for the survival of human society. New drugs are designed for therapeutic purposes to combat new diseases. Besides treating new diseases, new drug development is also needed to treat pre‐existing diseases more effectively and reduce the existing drugs' side effects. The design of drugs involves several steps, from the discovery of the drug molecule to its commercialization in the market. One of the most critical steps in drug design is to find the molecular interactions between the target (infected) molecule and the drug molecule. Several complex chemical equations need to be solved to determine the molecular interactions. In the late 20th Century, the advancement of computational technologies has made the solution of chemical equations relatively easier and faster. Moreover, the design of drug molecules involves multi‐criteria optimization. Classical computational methodologies have been used for drug design since the end of the 20th Century. However, nowadays, more advanced computational methodologies are inevitable in designing drugs for new diseases and drugs with fewer side effects. In this context, the quantum computing paradigm has proved beneficial in drug design due to its advanced computational capabilities. This paper presents a state‐of‐the‐art comprehensive review of the quantum computing‐based methodologies involved in drug design. A comparative study is made about the different quantum‐aided drug design methods, stating each methodology's merits and demerits. The review work presented in this manuscript will help new researchers assess the present state‐of‐the‐art concept of quantum‐based drug design. This article is categorized under: Technologies > Structure Discovery and Clustering Technologies > Computational Intelligence Application Areas > Health Care
Abstract Design and development of new drug molecules are essential for the survival of human society. New drugs are designed for therapeutic purposes to combat new diseases. Besides treating new diseases, new drug development is also needed to treat pre‐existing diseases more effectively and reduce the existing drugs' side effects. The design of drugs involves several steps, from the discovery of the drug molecule to its commercialization in the market. One of the most critical steps in drug design is to find the molecular interactions between the target (infected) molecule and the drug molecule. Several complex chemical equations need to be solved to determine the molecular interactions. In the late 20th Century, the advancement of computational technologies has made the solution of chemical equations relatively easier and faster. Moreover, the design of drug molecules involves multi‐criteria optimization. Classical computational methodologies have been used for drug design since the end of the 20th Century. However, nowadays, more advanced computational methodologies are inevitable in designing drugs for new diseases and drugs with fewer side effects. In this context, the quantum computing paradigm has proved beneficial in drug design due to its advanced computational capabilities. This paper presents a state‐of‐the‐art comprehensive review of the quantum computing‐based methodologies involved in drug design. A comparative study is made about the different quantum‐aided drug design methods, stating each methodology's merits and demerits. The review work presented in this manuscript will help new researchers assess the present state‐of‐the‐art concept of quantum‐based drug design. This article is categorized under: Technologies > Structure Discovery and Clustering Technologies > Computational Intelligence Application Areas > Health Care
Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.
The preservation of human health is of utmost importance, and unrestricted availability of medications is essential for the sustenance of overall wellness. Pharmaceuticals, which consist of a wide range of therapeutic substances utilized to diagnose, treat, and improve various diseases and conditions, play a crucial part in the field of healthcare. However, the drug research and development process is widely recognized for its lengthy duration, demanding nature, and substantial expenses. To enhance the effectiveness of this complex process, interdisciplinary groups have converged, giving rise to the field known as “Bioinformatics”. The emergence and future advancements of Quantum Computing (QC) technologies have the potential to significantly enhance and accelerate the complex process of drug discovery and development. This paper explores various disciplines, such as Computer-Aided Drug Design (CADD), quantum simulations, quantum chemistry, and clinical trials, that stand to gain significant advantages from the rapidly advancing field of quantum technology. This study aims to explore a range of fundamental quantum principles, intending to facilitate a thorough understanding of this revolutionary technology.
INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.
Drug discovery and development is a highly complex and costly endeavor, typically requiring over a decade and substantial financial investment to bring a new drug to market. Traditional computer-aided drug design (CADD) has made significant progress in accelerating this process, but the development of quantum computing offers potential due to its unique capabilities. This paper discusses the integration of quantum computing into drug discovery and development, focusing on how quantum technologies might accelerate and enhance various stages of the drug development cycle. Specifically, we explore the application of quantum computing in addressing challenges related to drug discovery, such as molecular simulation and the prediction of drug-target interactions, as well as the optimization of clinical trial outcomes. By leveraging the inherent capabilities of quantum computing, we might be able to reduce the time and cost associated with bringing new drugs to market, ultimately benefiting public health.
The pharmaceutical industry relies heavily on the drug discovery process to develop new medications that can help treat various diseases. This process is highly crucial but also very time-consuming, as it involves screening a massive number of chemical compounds to identify those that can be developed into effective treatments. Traditional computing methods are often inadequate for this task due to the complexity and vastness of the data involved. Quantum computing is an emerging field that has gained significant attention in recent years due to its ability to perform complex computations at a much faster pace than classical computers. Quantum computing uses the principles of quantum mechanics, which differ significantly from classical computing. Drug discovery involves a process of identifying new drugs with the desired biological activity to treat specific diseases. This process can be quite lengthy, time-consuming, and expensive, often taking many years to develop a single drug. However, quantum computing has the potential to revolutionize the drug discovery process. Its ability to perform complex calculations quickly and efficiently could significantly speed up the drug discovery process, making it more cost-effective and accurate. Quantum computing's potential in drug discovery requires further research to fully understand and develop practical applications. The use of quantum computing requires the development of specialized algorithms and software tailored to quantum computing. Further investment in research and development is needed to fully leverage the potential of this technology. This paper explores the potential of quantum computing in drug discovery. We will analyze the benefits of using quantum computing in drug discovery, including faster and more accurate data processing, improved optimization, and more efficient screening of chemical compounds. Our paper will also discuss the challenges and limitations that need to be addressed to fully leverage the potential of quantum computing in drug discovery. This will include discussing potential applications of quantum computing in drug discovery, as well as the need for further investment in research and development to fully realize the potential of this technology. Overall, our paper will provide a comprehensive analysis of the potential of quantum computing in drug discovery, exploring both the benefits and challenges associated with this technology and providing recommendations for future research and development.
Quantum AI, the integration of quantum computing and artificial intelligence, is revolutionizing drug design by addressing the limitations of traditional pharmaceutical development. This review explores its transformative potential in enhancing molecular simulations, structure-based, target-based, and ligand-based drug discovery, and personalized medicine. Quantum computing leverages principles like superposition, entanglement, and interference to perform complex calculations exponentially faster than classical systems, enabling precise modeling of molecular interactions. Algorithms such as the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE) outperform classical methods like Density Functional Theory (DFT) in accuracy and efficiency, facilitating the identification of promising drug candidates and optimizing their pharmacokinetic properties. Quantum AI also enhances personalized medicine by analyzing vast genomic datasets to tailor treatments, improving efficacy and minimizing adverse effects. Despite challenges, including noisy intermediate-scale quantum (NISQ) device limitations and the need for advanced error correction, ongoing research and interdisciplinary collaboration are driving progress. Quantum AI promises to reduce development costs, accelerate drug discovery, and democratize access to life-saving medications. By enabling simulation-based discovery and expanding drug-candidate libraries to include peptides and antibodies, it paves the way for breakthroughs in treating complex diseases. This review underscores the need for continued investment in quantum technology to fully harness its potential, positioning the pharmaceutical industry for a future where drug development is faster, more precise, and patient-centric, ultimately improving global healthcare outcomes.